BERNSTEIN HAROLD (President, R&D & CMO) sold 45K shares of MAZE THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.83M. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/31/2025ACC: 0002050172-25-000007
Officer· President, R&D & CMO
Since Mar 2026
-45K
Net shares
Net seller
$1.83M
Total sold
2
Open market trades
0B · 2S
4
Total transactions
45K acquired · 90K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+45K
Price / share
$10.42
Trade value
$468.90K
% of position
New position
12/29/2025
0.00→45K
Common Stock
Direct
Shares
−27.80K
Price / share
$40.34
Trade value
$1.12M
% of position
61.8%
12/29/2025
45K→17.20K
Common Stock
Direct
Shares
−17.20K
Price / share
$40.93
Trade value
$703.93K
% of position
New position
12/29/2025
17.20K→0.00
Total
Net shares
+0.00
Net value
-$1.36M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/29/2025 | M · Option Exercise | +45K | $10.42 | $468.90K | New position | 0.00 | 45K |
| Common Stock Direct | 12/29/2025 | S · Sale | −27.80K | $40.34 | $1.12M | 61.8% | 45K | 17.20K |
| Common Stock Direct | 12/29/2025 | S · Sale | −17.20K | $40.93 | $703.93K | New position | 17.20K | 0.00 |
| Total | +0.00 | -$1.36M | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
45K shares
Shares
−45K
Strike price
10.42
Held after
342.41K
Exercisable
—
12/29/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock45K shares | 12/29/2025 | M · Option Exercise | −45K | 10.42 | — | 342.41K |